Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection

Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection

COVID-19 (coronavirus disease 2019), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), stands as one of the most severe pandemics the world has ever faced in recent times. SARS-CoV-2 infection exhibits a wide range of symptoms, varying from severe manifestations to mild cases a...

Full description

Saved in:
Bibliographic Details
Main Authors: Mubashir Nazir, Ishfaq Rashid Mir, Shabir Ahmad Lone, Ghazala Muteeb, Ragib Alam, Anis Bashir Fomda, Nida Khan, Asim Azhar, Bashir Ahmad Fomda, Wajihul Hasan Khan
Format: Article
Language:English
Published: PeerJ Inc. 2025-06-01
Series:PeerJ
Subjects:
SARS-CoV-2
Innate immunity
STINGs
Signaling molecules
Monoclonal antibody
Online Access:https://peerj.com/articles/19462.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://peerj.com/articles/19462.pdf

Similar Items